Wildman Daniel George
SEC insider (Form 3/4/5 filer). CIK 0001952679. Director at UroGen Pharma Ltd. (URGN). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in PRINCETON, NJ.
Companies Wildman Daniel George has filed insider reports for
- UroGen Pharma Ltd. (URGN): Director
Wildman Daniel George
CIK: 0001952679
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
UroGen Pharma Ltd.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 22, 2026URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
10K shares- - Jun 22, 2026URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Unit
8K shares- - Nov 26, 2025URGN
UroGen Pharma Ltd.
ExerciseDirect2K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
10K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Unit
8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 10,000 | - | - | Direct |
| Jun 22, 2026 | URGN UroGen Pharma Ltd. | Award Restricted Stock Unit | 8,000 | - | - | Direct |
| Nov 26, 2025 | URGN UroGen Pharma Ltd. | Exercise | 2,000 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 10,000 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Restricted Stock Unit | 8,000 | - | - | Direct |
1-5 of 5 transactions